Extracellular Matrix Market is expected to reach US$ 52.72 million by 2028


PRESS RELEASE BY The Insight Partners 30 Dec 2021

Share this press on


Porcine Segment to Lead Extracellular Matrix Market During 2021–2028

 

According to our latest study, titled "Extracellular Matrix Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Raw Material and Application," the market is projected to reach US$ 52.72 million by 2028 from US$ 31.49 million in 2021. It is estimated to grow at a CAGR of 7.6% from 2021 to 2028. The report highlights the key factors influencing the market growth and prominent players and their strategies.

 

Several factors, such as the significant rise in CVDs and trauma and an increase in vascular reconstruction procedures, are boosting the extracellular matrix market. However, the challenges faced in using decellularized extracellular matrix hamper the market's growth.

 

Based on the raw material, the extracellular matrix market is segmented into bovine, porcine, and other raw materials. The porcine segment is expected to hold the largest share of 43.76% of the extracellular matrix market in 2021.

 

Extracellular matrices, made of porcine, are derived from porcine adipose tissue, urinary bladder, or mammary fatty tissues. The most common parts of pigs, such as skin and bones, are used to derive extracellular matrix. Matrices derived from skin and bone are commonly used for industrial purposes. Porcine collagen is almost similar to human collagen, and it does not cause an allergic response when used.

 

Based on the application, the extracellular matrix market has been segmented into soft tissue repair, dural repair, wound healing, cardiac repair, pericardial repair, and vascular repair and reconstruction. The soft tissue repair segment is likely to account for a larger market share in 2021. However, the vascular repair and reconstruction segment is expected to register a higher CAGR in the market during the forecast period.

 

Anteris, Aziyo Biologics, Inc.; Coloplast Group; Cook Biotech, Inc.; DSM Biomedical; Baxter International, Inc.; Medtronic; Merck KGaA; MTF Biologics; and Smith & Nephew are the leading companies operating in the extracellular matrix market.


Extracellular Matrix Market, by Region, 2021 (%)
Extracellular Matrix Market, by Region, 2021 (%)

Extracellular Matrix Market Size & Growth | Report, 2021-2028

Download Free Sample

Extracellular Matrix Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Raw Material (Bovine, Porcine, and Other Raw Material) and Application (Soft Tissue Repair, Dural Repair, Wound Healing, Cardiac Repair, Pericardial Repair, and Vascular Repair and Reconstruction)

 

The Extracellular Matrix Market has Been Segmented as Follows:

The extracellular matrix market is analyzed on the basis of the raw material and the application. Based on the raw material, the market is segmented as bovine, porcine, and other raw materials. Based on the application, it has been segmented into soft tissue repair, dural repair, wound healing, cardiac repair, pericardial repair, and vascular repair and reconstruction.


Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

Download Free PDF Brochure